Paper3693552
Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
Jones RN and 1 other. J Clin Microbiol, 1987. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods. Papers, record 3693552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3693552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Gram-Negative Bacteria | Major topic |
| Aztreonam | |
| Culture Media | |
| Microbial Sensitivity Tests | |
| Quality Control | |
| Regression Analysis |
Source PubMed
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6455443 | Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. | J Clin Microbiol | 1981 | https://conductscience.org/library/papers/6455443 | PubMed |
| 2 | 6358173 | Synthesis of sulfazecin-type 2-azetidinones with a carbon substituent at the 4-position. | J Antibiot (Tokyo) | 1983 | https://conductscience.org/library/papers/6358173 | PubMed |
| 3 | 6395801 | Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans. | Antimicrob Agents Chemother | 1984 | https://conductscience.org/library/papers/6395801 | PubMed |
| 4 | 3980309 | The in-vitro activity of Ro 17-2301, a new monobactam, compared with other antimicrobial agents. | J Antimicrob Chemother | 1985 | https://conductscience.org/library/papers/3980309 | PubMed |
| 5 | 3874598 | In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/3874598 | PubMed |
| 6 | 3121242 | Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicid. | Diagn Microbiol Infect Dis | 1987 | https://conductscience.org/library/papers/3121242 | PubMed |
| 7 | 3909316 | Aztreonam: antibacterial activity, beta-lactamase stability, and interpretive standards and quality control guidelines for disk-diffusion susceptibility tests. | Rev Infect Dis | 1985 | https://conductscience.org/library/papers/3909316 | PubMed |
| 8 | 4083866 | In vitro activity of carumonam. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4083866 | PubMed |
| 9 | 3729324 | Pharmacokinetics of carumonam in patients with renal insufficiency. | Antimicrob Agents Chemother | 1986 | https://conductscience.org/library/papers/3729324 | PubMed |
| 10 | 3096130 | The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactam. | Am J Clin Pathol | 1986 | https://conductscience.org/library/papers/3096130 | PubMed |
| 11 | 3536278 | In vitro activity of carumonam (RO 17-2301), BMY-28142, aztreonam, and ceftazidime against 7,620 consecutive clinical bacterial isolates. | Diagn Microbiol Infect Dis | 1986 | https://conductscience.org/library/papers/3536278 | PubMed |
| 12 | 4073864 | Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam. | Antimicrob Agents Chemother | 1985 | https://conductscience.org/library/papers/4073864 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 3190188 | In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila. | Antimicrob Agents Chemother | 1988 | https://conductscience.org/library/papers/3190188 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3693552
GET https://conductscience.org/api/papers/v1/3693552/authors